Cancer cells often exhibit resistance to therapies such as radiation and chemotherapy that induce DSBs. Enhanced NHEJ activity can allow these cells to repair therapy-induced DNA damage more effectively, contributing to resistance. For example, overexpression of NHEJ proteins like DNA-PKcs has been associated with poor prognosis and therapy resistance in various cancers.
